GeneReach Biotechnology Correlations

Stocks . Taiwan . 
Stock . GeneReach Biotechnology
4171 Stock  TWD 28.95  0.05  0.17%   
The current 90-days correlation between GeneReach Biotechnology and Yeou Yih Steel is 0.13 (i.e., Average diversification). The correlation of GeneReach Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

GeneReach Biotechnology Correlation With Market

Good diversification

The correlation between GeneReach Biotechnology and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to GeneReach Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneReach Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneReach Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneReach Biotechnology to buy it.

Moving together with GeneReach Stock

  0.794743 Oneness BiotechPairCorr
  0.886547 Medigen Vaccine BiologicsPairCorr
  0.944174 OBI PharmaPairCorr
  0.636541 Tanvex BioPharmaPairCorr
  0.844142 Adimmune CorpPairCorr
  0.842888 Shin Kong FinancialPairCorr
  0.852891C CTBC Financial HoldingPairCorr
  0.912888A Shin Kong FinancialPairCorr

Moving against GeneReach Stock

  0.912882B Cathay Financial HoldingPairCorr
  0.882891 CTBC Financial HoldingPairCorr
  0.842883 China DevelopmentPairCorr
  0.812881A Fubon Financial HoldingPairCorr
  0.812330 Taiwan SemiconductorPairCorr
  0.792317 Hon Hai PrecisionPairCorr
  0.772882A Cathay Financial HoldingPairCorr
  0.770057 Fubon MSCI TaiwanPairCorr
  0.760050 YuantaP shares TaiwanPairCorr
  0.680053 YuantaP shares TaiwanPairCorr
  0.674162 PharmaEnginePairCorr
  0.466589 EirGenixPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
2883B
+ 0.95
8044
2017
+ 0.73
9962
2850
+ 0.73
2883B
2017
+ 0.71
2029
2029
+ 0.68
9962
2029
+ 0.67
2849
  
High negative correlations   
2228
- 0.69
8044
2883B
- 0.61
2228
2017
- 0.56
8044
2017
- 0.43
2883B
2850
- 0.36
2228
2017
- 0.32
2850

Risk-Adjusted Indicators

There is a big difference between GeneReach Stock performing well and GeneReach Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GeneReach Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in GeneReach Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

GeneReach Biotechnology Corporate Management

Elected by the shareholders, the GeneReach Biotechnology's board of directors comprises two types of representatives: GeneReach Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GeneReach. The board's role is to monitor GeneReach Biotechnology's management team and ensure that shareholders' interests are well served. GeneReach Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GeneReach Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alison LeeChief OfficerProfile
Grace ChangChief OfficerProfile
David TsaiChief OfficerProfile
Simon ChungChief OfficerProfile
Yuwen HuangDeputy General Manager-Compliance & ProductionProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY